Johnson & Johnson $106.13

up +0.25


17/9/2014 11:46 AM  |  NYSE : JNJ  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get JNJ Trend Analysis - it has outperformed the S&P 500 by 1%

Partner Headlines

  1. New Active ETF for All Risk Environments

    Benzinga
  2. 3 Companies Investing In Stem Cell Research

    Benzinga
  3. Addressing Disengagement And Depression Lifts Workers

    IBD
  4. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD
  5. Steadier, Better: 35 Years Of Low-Volatility Stocks

    YCharts
  6. Johnson & Johnson Metal Hip Might Lead To Poisoning, Facing 6,000+ Suits

    Benzinga
  7. US Stock Futures Gain; ADP, Jobless Claims Data In Focus

    Benzinga
  8. Sharper Focus Pays Dividends At Johnson & Johnson

    IBD
  9. Drug M&A Boom Driven By Long-Term Trends: PwC

    IBD
  10. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD
  11. Morgan Stanley Sees Johnson & Johnson Taking Rx Estimates Higher

    Benzinga
  12. U.S., U.K. ISIS Response Differ Widely

    FoxBusiness
  13. Bank Of America Remains Optimistic On Johnson & Johnson

    Benzinga
  14. Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & ...

    Benzinga
  15. Focus On A Big-Picture Purpose To Get Top Results

    IBD
  16. Think Like An Owner

    GuruFocus
  17. Late-Cycle Nirvana: Moaty Dividends on the Cheap

    YCharts
  18. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  19. Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs

    GuruFocus
  20. Omnicom Offers Steady Profit Growth, Rising Dividend

    IBD
  21. #PreMarket Primer: Friday, August 22: Draghi, Yellen Set To Speak At Jackson ...

    Benzinga
  22. Illumina lines up key partners

    IBD
  23. Apple Stock Held By Institutional Investors Rises

    IBD
  24. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus
  25. Robert Wood Johnson's New Industry Made Surgery Safer

    IBD
  26. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  27. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  28. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD
  29. 3 Companies That Should Benefit From The New Initiative In Africa

    Benzinga
  30. #PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of ...

    Benzinga
  31. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus
  32. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus
  33. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  34. Why Procter & Gamble Surged Higher On Friday?

    GuruFocus
  35. Outlook for August 2014

    GuruFocus
  36. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD
  37. Unique 3D Startups And The Public Companies That Should Buy Them

    Benzinga
  38. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  39. Limiting Risk: A Little Exposure To High Yield Goes A Long Way

    GuruFocus
  40. What's the Right PE Ratio?

    GuruFocus
  41. Omnicom Tops Forecasts Despite Failed Publicis Merger

    IBD
  42. BlackRock: Stocks Iffy, But Not These Pockets

    YCharts
  43. YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation

    Benzinga
  44. Just Post-It: 3M Is a Good Bet for Your Portfolio Today

    GuruFocus
  45. Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit

    Benzinga
  46. ...

    GuruFocus
  47. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  48. The 10 Most-Respected Corporate Brands

    Benzinga
  49. Stocks To Watch For July 22, 2014

    Benzinga
  50. Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?

    Benzinga
Trading Center